Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Letters to the Editor

  • You have access
    A Comment on “Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression”
    Rui Lai, Dehai Xian, Lingyu Yang, Jing Song and Jianqiao Zhong
    Journal of Pharmacology and Experimental Therapeutics March 2018, 364 (3) 447-448; DOI: https://doi.org/10.1124/jpet.117.246074
  • You have access
    Rosuvastatin and Its Evolving Role as a Vascular Remodeling and Antiproliferative Agent in Different Systemic Malignancies
    Shailendra Kapoor
    Journal of Pharmacology and Experimental Therapeutics March 2017, 360 (3) 434; DOI: https://doi.org/10.1124/jpet.116.239400
  • You have access
    Tenofovir Disoproxil Fumarate Is Not an Inhibitor of Human Organic Cation Transporter 1
    Hong Shen, Wenying Li, W. Griffith Humphreys and Yurong Lai
    Journal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 341-342; DOI: https://doi.org/10.1124/jpet.116.238337
  • You have access
    The Glutamate Model of Schizophrenia: It’s All About Signal Muscarinic Connections
    Costa Vakalopoulos
    Journal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 288; DOI: https://doi.org/10.1124/jpet.116.238766
  • You have access
    A Comment on “Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8”
    Jeffrey M. Witkin and Kevin M. Gardinier
    Journal of Pharmacology and Experimental Therapeutics September 2016, 358 (3) 502-503; DOI: https://doi.org/10.1124/jpet.116.234419
  • You have access
    Reply to “A Comment on ‘Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8’”
    Michael P. Maher, Michael K. Ameriks, Brad M. Savall, Nicholas I. Carruthers and Timothy W. Lovenberg
    Journal of Pharmacology and Experimental Therapeutics September 2016, 358 (3) 527; DOI: https://doi.org/10.1124/jpet.116.234815
  • You have access
    Comments on “Ethanol Sensitivity of GABAergic Currents in Cerebellar Granule Neurons Is Not Increased by a Single Amino Acid Change (R100Q) in the α6 GABAA Receptor Subunit”
    Thomas S. Otis
    Journal of Pharmacology and Experimental Therapeutics January 2008, 324 (1) 399-400; DOI: https://doi.org/10.1124/jpet.107.131557
  • You have access
    Response to Comment on “Ethanol Sensitivity of GABAergic Currents in Cerebellar Granule Neurons Is Not Increased by a Single Amino Acid Change (R100Q) in the α6 GABAA Receptor Subunit”
    C. Fernando Valenzuela, Richard A. Radcliffe, Paolo Botta and Manuel Mameli
    Journal of Pharmacology and Experimental Therapeutics January 2008, 324 (1) 401-403; DOI: https://doi.org/10.1124/jpet.107.132746
  • You have access
    Comments on “Blockade of Angiogenesis by Small Molecule Antagonists to Protease-Activated Receptor-1: Association with Endothelial Cell Growth Suppression and Induction of Apoptosis”
    C. Di Serio, S. Pellerito and F. Tarantini
    Journal of Pharmacology and Experimental Therapeutics January 2008, 324 (1) 404-405; DOI: https://doi.org/10.1124/jpet.107.131847
  • You have access
    Response to Comments on “Blockage of Angiogenesis by Small Molecule Antagonists to Protease-Activated Receptor-1: Association with Endothelial Cell Growth Suppression and Induction of Apoptosis”
    N. E. Tsopanoglou and M. E. Maragoudakis
    Journal of Pharmacology and Experimental Therapeutics January 2008, 324 (1) 406-407; DOI: https://doi.org/10.1124/jpet.107.132282

Pages

  • Next
  • 1
  • 2
  • 3
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics